Short answer
SBC Medical Group Holdings Inc (SBC) filed an 8-K current report with the SEC on July 14, 2026 reporting Item 3.01 (Notice of Delisting), Item 5.07 (Submission of Matters to a Vote of Security Holders). Nasdaq noncompliance triggered by Mike Sayama’s departure from the Board and Audit Committee.
- This filing includes Item 3.01, an item that often signal trouble.
SBC Medical Group Holdings Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 3.01 · Notice of Delisting
- Nasdaq noncompliance triggered by Mike Sayama’s departure from the Board and Audit Committee
- Board now four members, with two independent directors; Audit Committee has two independent members
- Nasdaq cure period runs until the earlier of the next annual meeting or July 9, 2027
- Earlier annual meeting requires compliance evidence by January 5, 2027
- Company seeking a fifth independent director; no immediate effect on Nasdaq listing while cure period remains available
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 93,987,291 shares represented, establishing a strong quorum against 102,576,943 shares entitled to vote
- All four director nominees elected through the 2027 annual meeting, with 89,910,053–90,426,406 votes supporting
- MaloneBailey, LLP appointment ratified for fiscal 2026 with 93,954,650 votes for
- Stockholders approved charter changes enabling removal of directors without cause and replacing plurality voting requirements
- Stockholders also approved DGCL Section 203 opt-out and officer exculpation, expanding governance flexibility and liability protection
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SBC Medical Group Holdings Inc 8-K filings
Get the next SBC 8-K as it lands
Follow SBC for push alerts, or ask the research agent what this filing means.